Biotech company Prima BioMed , chaired by Lucy Turnbull , is set to reveal some interim data on its Phase 11b trial for its chief ovarian cancer vaccine today.

If the update is positive, it will bode well for new chief executive Matt Lehman in his meetings with investors at this week’s ASX Small Caps conference in Hong Kong.